About this trial
To create a research repository of patients with known degenerative cervical myelopathy (DCM) and a control cohort of subjects who have non-myelopathic spinal disease. This repository will be used to assess functional and/or biological measures that may allow for improved prediction of symptomatic progression and response to treatment in patients with DCM. In addition, this repository will be used to develop a risk assessment scale to accurately predict functional outcomes following operative management of DCM.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of degenerative cervical myelopathy
Diagnosis of cervical degenerative disease without myelopathy
Disqualifiers
None outside or diagnostic requirements and age limits.
Trial population
The study population will be those diagnosed with degenerative cervical myelopathy, and those with cervical degenerative disease who do not experience myelopathic symptoms. Participating subjects will be required to sign the approved informed consent.
Trial design
Case-control
Prospective
Treatments tested in this trial
Standard clinical care procedures and outcome measurements.
Other interventionStandard of care surgical interventions, imaging impressions, laboratory results, and outcome measurements will be collected and analyzed.
Treatment groups
Trial outcomes
Primary outcomes
Data comparison between DCM and control groups
This study is to determine biomarkers associated with DCM and analyze objective clinical measures to determine more predictable and potentially effective treatments for patients diagnosed with cervical myelopathy.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Francis Farhadi
Lead sponsor
University of Kentucky
Sponsor institution